What is Emergent BioSolutions Forward Dividend Yield %?
As of today (2024-04-28), the Forward Annual Dividend Yield of Emergent BioSolutions is 0.00%.
As of today (2024-04-28), the Trailing Annual Dividend Yield of Emergent BioSolutions is 0.00%.
EBS's Forward Dividend Yield % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.89 * Ranked among companies with meaningful Forward Dividend Yield % only.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
Competitive Comparison of Emergent BioSolutions's Forward Dividend Yield %
For the Drug Manufacturers - Specialty & Generic subindustry, Emergent BioSolutions's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Emergent BioSolutions's Forward Dividend Yield % Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Emergent BioSolutions's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Emergent BioSolutions's Forward Dividend Yield % falls into.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Emergent BioSolutions Forward Dividend Yield % Related Terms
Thank you for viewing the detailed overview of Emergent BioSolutions's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.
Emergent BioSolutions (Emergent BioSolutions) Business Description
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company has four main units: vaccines, which produces specialty vaccines for public health threats; devices, such as nasal sprays, skin lotions, and injections; therapeutics, which includes antibody-based treatments; and contract development and manufacturing, which brings treatments to market through collaboration with the pharmaceutical and biotechnology industries and the United States government. Most revenue comes from U.S. government purchases of vaccines, devices, and therapeutic products. The company operates in two reportable segments; the Products Segment and the Services Segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
EBS has been successfully added to your